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Galectin-8 (Gal-8) is amammalian lectin endowedwith immunostimulatory ability.
In the present work, we demonstrate that Gal-8-glycan interactions on the sur-
face of antigen-presenting cells (APCs) promote antigen binding and internaliza-
tion, independently from antigen nature. Both Gal-8 and antigen were together
internalized and localized in early endosomes. Interestingly, antigen processing
by APCs was also accelerated in the presence of Gal-8 as a separate mechanism,
distinct from the increased antigen internalization. Moreover, APCs pulsed
together with antigen and Gal-8 were able to activate cognate CD4+ T cells
more efficiently than those pulsed with antigen alone. This enhanced antigen pre-
sentation was still evident in the absence of costimulatory signals and APCs-
derived soluble mediators. Therefore, our results provide evidence for as yet un-
recognized mechanism by which Gal-8 stimulates the elicitation of the immune
response in a lectin-dependent manner, by inducing antigen uptake and process-
ing upon lattice formation at APCs surface.
INTRODUCTION
Galectins (Gals) comprise a family of mammalian lectins characterized by the presence of at least one car-
bohydrate recognition domain (CRD) that binds to N-acetyl-lactosamine-containing glycans. By engaging
different glycosylated ligands, Gals can mediate multiple cellular functions like adhesion, apoptosis, differ-
entiation, activation, andmigration (Elola et al., 2007; Johannes et al., 2018). A particular feature of this fam-
ily is the building of ordered cell surface Gal-glycan lattices, which induce the aggregation of specific gly-
coconjugates leading to cell signaling regulation (Brewer, 2002). Gals are synthesized as cytoplasmic
proteins to be eventually secreted as soluble factors by a non-classical mechanism. Upon their release,
they can bind to glycoproteins and glycolipids present on the cell surface, re-enter the cell by endocytosis,
and occupy endocytic and recycling compartments (Johannes et al., 2018; Lepur et al., 2012). Given their
particular distribution, Gals can act either intra or extracellularly, thus being involved in diverse cellular pro-
cesses. Different members of this family have been found in lymphoid tissues, and accumulative evidence
has positioned Gals as key mediators of the innate and adaptive immune responses (Liu and Rabinovich,
2010; Martı́nez Allo et al., 2018).
Galectin-8 (Gal-8), from the tandem-repeat subgroup, is composed of two covalently linked N- and C-ter-
minal CRDs, each displaying different ligand affinity (Stowell et al., 2008). It is expressed in several tissues
under normal or pathologic conditions such as inflammation, autoimmunity, and tumors (Elola et al., 2007;
Eshkar Sebban et al., 2007; Weinmann et al., 2018). Gal-8 is receiving special attention in terms of its role in
the immune system, as its participation in a broad spectrum of functions both stimulating or controlling
innate and adaptive responses have been demonstrated (reviewed in Tribulatti et al., 2020). In particular,
our group has reported an activating ability during the elicitation of primary antigen-specific responses,
postulating Gal-8 as an immunostimulatory molecule (Carabelli et al., 2017; Tribulatti et al., 2009). Among
the underlyingmechanisms of this stimulatory effect, we found that Gal-8 costimulates naiveCD4+ T cells in
the presence of antigen and antigen-presenting cells (APCs), strengthening TCR signaling, particularly
when antigenic signals are weak (Tribulatti et al., 2012). Gal-8 was shown to induce full activation of mouse
bone marrow-derived dendritic cells (BMDCs) as well as endogenous splenic dendritic cells (DCs), charac-
terized by an increment of costimulatory molecules, an augmented capacity to activate antigen-specific
CD4+ T cell responses, and a strong production of IL-6, among other inflammatory cytokinesiScience 23, 101278, July 24, 2020 ª 2020 The Author(s).





Article(Carabelli et al., 2017). Moreover, we have recently demonstrated that the enhanced levels of IL-6 produced
by Gal-8-activated splenic APCs synergize the TCR signaling during antigen presentation to CD4+ T cells,
resulting in the Gal-8 costimulatory effect (Carabelli et al., 2018).
DCs are the most efficient APCs endowed with a unique capacity to activate naive T cells, and therefore to
initiate and direct the adaptive immune response (Steinman, 2006). Immature DCs are localized in periph-
eral tissues where they efficiently capture antigens through constitutivemacropinocytosis, phagocytosis, or
receptor-mediated endocytosis. These antigens are further processed into peptides and then loaded onto
major histocompatibility complex type II (MHC-II) molecules and presented on the DC surface. When DCs
capture antigen in the presence of microbial products or other inflammatory stimuli, they undergo marked
morphological and functional changes, called maturation, to optimize antigen presentation to T cells.
These changes include an increased migratory capacity to reach lymphoid tissues where T cells reside,
acidification of lysosome compartment to promote antigen processing, and up-regulation of costimulatory
molecules at DC surface (Mellman and Steinman, 2001; Steinman, 2006). Moreover, it has been described
that TLR-induced DCmaturation involves an early and transient endocytosis enhancement that can be used
to boost antigen capture and presentation (West et al., 2004). In fact, several vaccine adjuvants that induce
the activation of adaptative T cell response via DCs were shown to display a direct role in antigen uptake as
a mechanism of action (Ahmad et al., 2017; O’Hagan et al., 2012; Reed et al., 2013).
It has been largely reported that different Gals can modulate the uptake of cargo proteins through their
interaction with glycoproteins and glycosphingolipids at the cell surface (Furtak et al., 2001; Lakshminar-
ayan et al., 2014; Mathew and Donaldson, 2018; Zappelli et al., 2012). For example, Gal-3 was shown to
induce CD44 and b1-integrin internalization, involving the clustering of specific glycoconjugates and the
generation of membrane curvature, leading to the formation of tubular endocytic pits (Lakshminarayan
et al., 2014). Whether Gals are also able to mediate the internalization of soluble molecules or particles
within a functional context is, however, poorly addressed.
Since Gal-8-induced costimulation of specific CD4+ T cell response occurs necessarily in the simultaneous
presence of APCs, T cells, and cognate antigen, we propose that Gal-8 can modulate antigen uptake and
subsequent processing leading to a more efficient antigen presentation and immune response elicitation.
In this study, we analyzed the role of extracellular Gal-8 in antigen internalization, processing, and presen-
tation using BMDCs as model APCs.
RESULTS
Galectin-8 Is Early Internalized by BMDCs in a Glycosylation-Dependent Manner
In the first place, we characterized the internalization of Gal-8 by immature BMDCs, a well-established
model for professional phagocytes that are suitable for soluble or particulated antigen uptake. BMDCs
were incubated at 37C in the presence of Alexa 488-Gal-8, and endocytosis was analyzed by confocal mi-
croscopy. Gal-8 was early internalized (from 5min) inside cytoplasmic vesicles, which increased in size along
the incubation time (Figure 1A). At the initial time point (0 min), Gal-8 was also found attached to the cell
surface, suggesting that Gal-8 first bound to the outer membrane glycoconjugates being readily internal-
ized through active endocytosis. To test this, BMDCs were incubated on ice for 20 min with Alexa 488-Gal-8
in the presence of lactose as a Gal-inhibitor and the binding to the cell surface was analyzed by flow cytom-
etry. The histogram depicted in Figure 1B confirmed that Gal-8 binds to the cell surface in a lectin-glycan-
dependent manner since lactose displaced Gal binding. In support, reduced Gal-8 binding to BMDCs sur-
face and subsequent internalization in the presence of lactose was also shown by confocal microscopy (Fig-
ure 1C). A fluorescent-labeled mutant Gal-8 (Gal-8mut) that preserves the selective glycan-recognition
ability for high-affinity ligands of theC-CRD, such as poly-N-acetyl-lactosamines and blood group antigens
(Schroeder et al., 2016), was similarly endocytosed by BMDCs (Figure 1D). Taken together, these results
highlight that Gal-8 is early internalized by BMDCs, involving the recognition of glycans of broad specificity
at the cell surface.
Gal-8 Induces Antigen Binding and Uptake by BMDCs
It has been reported that extracellular galectin-glycan interactions play important roles in the endocytosis
of different cargo proteins (Lakshminarayan et al., 2014; Mathew and Donaldson, 2018). Considering that
Gal-8 is able to stimulate the antigenic response (Carabelli et al., 2017), we hypothesize that Gal-8-built lat-
tices at the cell surface could enhance antigen uptake by DCs, as an additional immunostimulant2 iScience 23, 101278, July 24, 2020
Figure 1. Galectin-8 Is Early Internalized by BMDCs in a Glycosylation-Dependent Manner
(A) BMDCs were incubated with 0.2 mM Alexa 488-Gal-8 on ice (0 min) or at 37C for 5, 15, 40, and 60 min. Representative confocal microscopy images from
each condition are shown. Scale bar: 10 mm.
(B and C) BMDCs were incubated on ice with 0.2 mM Alexa 488-Gal-8 alone (Gal-8) or in combination with 100 mM lactose in 1X PBS (Gal-8 +Lac). Cells
without Gal-8 were used as control (B). Cell surface fluorescent signal was analyzed by flow cytometry (B) or confocal microscopy (C). Representative confocal
microscopy images are shown. Scale bar: 10 mm.




Articlemechanism. To test this, we used fluorescent-labeled ovalbumin (OVA) as a model antigen. BMDCs were
incubated at 37C in the presence of Alexa 488-OVA together with 2 mM of unlabeled Gal-8 for different
time points, and internalization was analyzed by flow cytometry. The selection of Gal-8 concentration
used from here on was based on its previously reported ability to induce lattice structures formation (Cat-
taneo et al., 2011; Tribulatti et al., 2009). As shown in Figure 2A, cells internalized soluble antigen more effi-
ciently when co-incubated with Gal-8 for the periods tested (10 and 45 min). Moreover, when Gal-8-glycan
interaction was disrupted with lactose, the increment in antigen internalization was no longer observed,
indicating that galectin-glycan interactions were involved in this phenomenon (Figure 2B). When assays
were repeated incubating cells on ice instead of at 37C, no fluorescent signal beyond control cells was
observed in OVA-treated cells, confirming that the antigen was internalized by an active endocytic process
(Figure 2C). However, OVA fluorescent signal was unexpectedly increased when cells were co-incubated
with Gal-8 at low temperature, in a lectin-glycan-dependent manner, suggesting that Gal-8-built lattice
is somehow promoting antigen binding at BMDCs surface. In support, the same observation was obtained
by confocal microscopy (Figure 2D). The question of whether Gal-8 might be directly interacting with OVA
to mediate antigen binding and internalization, either in a lectin-glycan-dependent or -independent
manner, arises. However, after many efforts performing OVA-Gal-8 ‘‘pull-down’’ assays as detailed in
Methods, we were unable to determine if these proteins are actually interacting (not shown). Therefore,
the fact that Gal-8 promotes OVA binding to drive its internalization would not be a consequence of direct
interaction between these two proteins, but instead could be intrinsic to Gal-8 interaction with cell surface
glycans. At the same time, these findings support the notion that Gal-8 activity may not be specific for OVA
protein. Since soluble OVA is internalized by immature APCs mainly by mannose receptor (MR) and pino-
cytosis (Burgdorf et al., 2007), we wondered whether Gal-8 could induce internalization independently of
antigen nature and/or cell surface receptors. To address this, b-casein was selected as a non-glycosylated
antigen (Holland, 2008). BMDCs were incubated at 37C with biotinylated b-casein in the presence of un-
labeled Gal-8. After 20 min incubation, internalized b-casein was observed by labeling permeabilized cells
with Alexa 488-streptavidin followed by flow cytometry analysis. Remarkably, Gal-8-glycan interaction also
induced b-casein endocytosis, indicating that this effect may be independent of the antigen nature and/or
the endocytic mechanism (Figure 2E). Internalization indexes of both OVA and b-casein antigens in the
presence or absence of Gal-8 are depicted in Figure S1. Interestingly, binding of b-casein to the cell surface
was also promoted by Gal-8 (Figure 2F), further highlighting that galectin-glycan interaction permits anti-
gen association at the cell surface, probably representing a required initial step for the Gal-8-induced an-
tigen uptake enhancement. Next, we investigated whether Gal-8 and the antigen follow the sameiScience 23, 101278, July 24, 2020 3
Figure 2. Gal-8 Induces Antigen Binding and Uptake by BMDCs
BMDCs were incubated for the indicated time points with 50 mg/mL Alexa 488-OVA (A–D) or 50 mg/mL biotin-b-casein
(E and F) with the simultaneous addition of 2 mM Gal-8; at 37C for internalization (A, B, and E) or 15 min on ice for
cell surface binding (C, D, and F). Where indicated, 100 mM lactose in 1X PBS (Lac) was added together with the stimulus
(B - F). For biotin-b-casein detection, cells were fixed and permeabilized before intracellular staining with Alexa
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488-streptavidin. The fluorescence signal was analyzed by flow cytometry (A–C, E, and F) or by confocal microscopy
(D). Normalized fluorescence intensity of fifteen fields from each condition was registered using FIJI software. Scale
bar: 10 mm (D). Bars represent the mean of fluorescence intensity (MFI) G SD. In all cases, unstimulated cells were used
as control. *p < 0.05, **p < 0.01, ****p < 0.0001 (t test). Depicted assays are representative of at least three




Articleintracellular route after internalization by analyzing their subcellular localization. BMDCs were incubated
simultaneously with Alexa 488-Gal-8 and Alexa 568-OVA at 37C for 5 and 15 min. Then, cells were washed
and fixed, and fluorescence signals were analyzed by confocal microscopy. For longer periods, BMDCs
were first pulsed with both fluorescent-labeled stimulus for 15 min, washed, and then chased for another
15, 30, or 60 min at 37C until cell fixation and microscopic analysis. Notably, a tight association between
these two proteins inside cytoplasmic vesicles was readily observed at all the time points tested as shown in
Figure 3A, suggesting that Gal-8 is internalized together with the antigen following the same endocytic
pathway. Manders’ colocalization coefficients for Gal-8 overlapping OVA signal and OVA overlapping
Gal-8 signal were calculated. About 60%–85% of both proteins colocalized during all periods tested (Fig-
ure 3A). Then, to elucidate the intracellular fate of internalized OVA and Gal-8, the colocalization with
different subcellular markers was analyzed. For this purpose, BMDCs were simultaneously incubated at
37C with Alexa 488-Gal-8 and Alexa 568-OVA for 5, 15, and 20 min or pulsed for 15/20 min and chased
for another 15 or 40 min, and then cells were labeled for EEA1, Rab-5, Lamp1, and Rab-7 subcellular
markers (Figures 3B and S2). Manders’ coefficients for OVA and Gal-8 overlapping with the marker signal
were calculated to determine the fraction of each protein on the corresponding compartment. More than
60% of OVA and Gal-8 signal were found inside EEA-1+ and Rab-5+ vesicles at 20 min post exposure, indi-
cating that both proteins were directed to early endosome compartments after internalization (Figure 3B).
At longer post-internalization times, OVA and Gal-8 localization in early endosomes decreased as ex-
pected, and only a smaller proportion of these proteins (about 45%) were observed inside Rab-7+ or
Lamp-1+ vesicles (Figures 3B and S2). The apparent exclusion of Gal-8 and OVA signals from these com-
partments can be attributable to the fact that antigens are rapidly degraded when they enter the endo-
lysosomal pathway in BMDCs. Taken together, these findings demonstrate that OVA antigen and Gal-8
are conjointly internalized by BMDCs and also delineate the intracellular route followed after their
endocytosis.
Gal-8 Can Activate Antigen Processing Independently of Uptake
Next, we aimed to investigate whether antigen internalization induced in the presence of Gal-8 affected the
subsequent degradation. For this purpose, BMDCs were incubated with Gal-8 and DQ-OVA, a self-
quenched conjugate of OVA that exhibits bright fluorescence upon proteolytic degradation, followed
by flow cytometry analysis. As depicted in Figure 4A, the presence of Gal-8 resulted in an increased intra-
cellular antigen degradation after 30- and 60-min incubation, confirming that the enhanced OVA signal
previously observed in Figures 2A and 2B was not a consequence of reduced or delayed degradation
but rather relies upon an augmented internalization rate. Differences in fluorescent signals between
DQ-OVA and DQ-OVA +Gal-8 treatments were no longer observed after 2-h incubation (not shown), prob-
ably because the probe is reaching a complete degradation at this time as previously reported (Olatunde
et al., 2018). Notably, Gal-8-induced degradation was reduced in the presence of lactose indicating that
the pro-degradative effect also relied upon lectin-glycan interaction (Figure 4A). Since both stimuli were
present in the media during incubation, the augmented DQ-OVA signal induced by Gal-8 could be the
result of an accelerated degradation or secondary to an increased internalization. To address this issue,
BMDCs were first pulsed with DQ-OVA and Gal-8 for 15 min, washed out, and further incubated for another
15, 45, and 105 min. Histograms depicted in Figure 4B show an increased degradation in cells pulsed in the
presence of Gal-8, in agreement with our previous observations. Notably, there was a population of cells
pulsed with DQ-OVA plus Gal-8 that displayed a delay in antigen degradation at the earlier time points
after the pulse (15 and 45 min). We hypothesized that this population could be ‘‘saturated’’ of antigen
due to an augmented internalization induced by Gal-8 during the pulse. However, since BMDCs constitute
a heterogeneous group of cells, we cannot discard that these populations respond differently to Gal-8
stimuli. Nevertheless, even assuming that cells had internalized more antigen in the presence of Gal-8,
there is another population that exhibited an increased degradation, even at the earliest point (15 min).
These observations led us to consider that Gal-8 would be acting by two separate mechanisms: on the
one hand by building lattices with cell surface glycoproteins and facilitating antigen internalization/pino-
cytosis and on the other by intrinsically activating antigen processing. To unequivocally separate these twoiScience 23, 101278, July 24, 2020 5
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Figure 3. OVA Antigen and Gal-8 Colocalize in the Subcellular Compartments after their Joint Internalization
(A) BMDCs were incubated with 50 mg/mL Alexa 488-OVA and 0.2 mM of Alexa 568-Gal-8 plus 1.8 mM of unlabeled Gal-8
for 5 or 15 min, or were first pulsed during 15 min, washed, and chased for 15, 30, or 60 min. Representative images from
confocal microscopy are shown.
(B) BMDCs were treated as in (A) for the indicated time points, then cells were fixed, permeabilized, and stained with
anti-EEA1, -Rab5, -Lamp1, and -Rab7. Representative images from confocal microscopy are shown.
Quantification of colocalization of Gal-8 in OVA or Marker signal and colocalization of OVA in Gal-8 or Marker signal was
analyzed with Manders’ overlap coefficient, which were calculated using the JACOP plugin on FIJI setting the threshold
manually. Scale bars:10 mm. Bars represent the mean G SD of Manders coefficient from 10 fields containing at least two




Articlemechanisms, we designed an assay that allowed us to demonstrate that both abilities were induced by Gal-
8. For this purpose, J774 macrophages were used as APCs, as this cell line is more adequate for this exper-
imental setting. Cells were pulsed for 20 min with DQ-OVA plus biotinylated OVA, washed, and incubated
for another 20 min. When Gal-8 was added during the pulse, cells not only internalized more biotin-OVA
but also degraded more DQ-OVA, thus confirming that the simultaneous addition of Gal-8 and antigen
induced both antigen internalization and proteolytic degradation by immature APCs (Figure 4C). On the
other hand, when Gal-8 was added after the mixed antigen pulse, it induced antigen degradation in the
absence of further internalization, indicating that antigen degradation induction is independent of its
enhanced internalization. Altogether, these findings support an important role for exogenous Gal-8 during
antigen uptake and processing and also stress the need for the simultaneous presence of Gal-8 and the
antigen to achieve antigen uptake enhancement.
Gal-8 is actively secreted by cells and could remain attached to the surface through interaction with glyco-
conjugates. To assess whether endogenous Gal-8 may exhibit the ability to induce antigen internalization
and processing, assays were repeated with BMDCs obtained from Lgals8/ mice and its C57BL/6J wild-
type (WT) counterpart. As observed in Figure 4D, the absence of endogenous Gal-8 did not alter DQ-OVA
internalization and/or degradation since no differences in DQ-OVA signal were recorded between
Lgals8/ and WT BMDCs. It is conceivable that the presence of other abundant Gals at the cell surface,
such as Gal-1 and Gal-3, could counteract Gal-8-induced antigen internalization and processing. Possibly,
elevated local amounts of endogenous Gal-8 such as those achieved under inflammatory conditions (which
can be recapitulated with exogenous addition of recombinant protein) are needed to effectively build a
lattice and further counteract the effect of other Gals-formed lattices. In fact, when recombinant Gal-8
was added in combination with DQ-OVA, the increased fluorescence signal was likewise observed in
both Gal-8-deficient and WT cells (Figure 4D), further indicating that the exogenous Gal-8 is sufficient to
induce antigen internalization and degradation.
BMDCs Pulsed with OVA and Gal-8 Present Antigen More Efficiently
After being internalized by APCs, antigens are directed to lysosomal compartments where they are pro-
cessed to originate peptides that accommodate onto molecules, to be presented to cognate T cells.
Therefore, we asked whether the increased antigen internalization and processing in the presence of
Gal-8 was traduced in a more efficient recognition and activation of specific T cells. When naive CD4+
T cells purified from TCROVA transgenic OT-II mice were cultured in the presence of BMDCs previously
pulsed for 45 min with OVA and Gal-8, a significant increased T cell proliferation and IFN-g secretion
were recorded, compared with cells pulsed with OVA only (Figure 5A). Remarkably, when this assay was
repeated using the cognate OVA peptide (OVA323-339) instead of the whole protein, no differences in
T cell activation were registered when the pulse was performed either in the presence or absence of
Gal-8 (Figure 5A). The latter strongly suggests that the enhanced T cell activation was a result of a greater
antigen presentation by BMDCs that had internalized and processed more OVA in the presence of Gal-8.
To confirm that Gal-8 was increasing antigen presentation to T cells, independently from its previously re-
ported activating effect on APCs (Carabelli et al., 2017), we repeated the assay depicted in Figure 5A, but in
this case BMDCs were fixed with glutaraldehyde after the pulse. As shown in Figure 5B, fixed BMDCs pre-
viously pulsed in the presence of Gal-8, induced a more efficient antigen presentation to T cells, even when
costimulatory signals and APCs-derived soluble factors were not involved. This result indicates that Gal-8-
pulsed BMDCs display increased levels of MHC-II-antigen complexes at the surface. We have previously
demonstrated that Gal-8 activates APCs to produce IL-6 during antigen presentation and that interleukin
signaling is involved in the Gal-8-induced elicitation of CD4+ T cell antigenic response (Carabelli et al.,
2018). Given that IL-6 was demonstrated to positively regulate cathepsin S expression in DCs (Kim et al.,iScience 23, 101278, July 24, 2020 7
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Figure 4. Gal-8 Can Activate Antigen Processing Independently of Uptake
(A) BMDCs were incubated with 50 mg/mL DQ-OVA for 30 or 60 min at 37C in the presence of 2 mMGal-8, with or without
100 mM lactose in 1X PBS (Lac).
(B) BMDCs were pulsed with 50 mg/mL DQ-OVA together with 2 mMGal-8 for 15 min at 37C. Then cells were washed and
chased for the indicated times.
(C) BMDCs were pulsed with 50 mg/mL DQ-OVA and 50 mg/mL biotin-OVA (bOVA) for 20 min at 37C in the presence (top)
or absence (bottom) of 2 mM Gal-8. Then, cells were washed and incubated for another 20 min at 37C in the presence
(bottom) or absence (top) of 2 mMGal-8. For biotin-OVA detection, cells were fixed and permeabilized before intracellular
staining with PE-Cy5-streptavidin.
(D) BMDCs differentiated from Lgals8/ or C57BL/6J (WT) mice were pulsed with 50 mg/mL DQ-OVA together with 2 mM
Gal-8 for 15 or 60 min at 37C.
Fluorescence emitted by the hydrolyzed DQ-OVA probe and PE-Cy5-streptavidin was analyzed by flow cytometry. Bars
represent the mean of fluorescence intensity (MFI) G SD. In all cases, unstimulated cells were used as control. *p < 0.05,
**p < 0.01, ***p < 0.001(A and C, t test). *p < 0.05, ****p < 0.0001 (D, ANOVA). Depicted assays are representative of at




Article2017), we wondered whether this cytokine could be participating in Gal-8-induced antigen processing. To
answer this question, BMDCs were differentiated from Il6/mice (Il6/BMDCs) or C57BL/6J control mice
(WT BMDCs) and pulsed with DQ-OVA and Gal-8. Both IL-6-deficient and WT BMDCs showed increased
antigen proteolysis in the presence of Gal-8, indicating that IL-6 signaling does not participate in Gal-8-
induced antigen processing (Figure S3A). Moreover, no differences were observed between the anti-
gen-presentation ability of fixed IL-6-deficient and WT BMDCs pulsed in the presence of Gal-8, thus dis-
regarding any effect of IL-6 signaling in Gal-8-induced internalization and processing (Figure S3B).
Taken together, our results provide supporting evidence that Gal-8 is able to induce binding, internaliza-
tion, and processing of soluble antigens by APCs, to increment presentation to specific CD4+ T cells, as an
additional mechanism of its immunostimulatory effect.
DISCUSSION
The Gals-glycan interaction is a complex field that is in continuous development. Here, we demonstrated
that Gal-8-glycan interaction at the cell surface canmodify soluble antigen internalization by APCs, a crucial
step in the elicitation of a given immune response. It has been previously shown that Gal-8 binding to cell
surface glycans constitutes an initial requirement for its subsequent internalization by a non-clathrin, non-
caveolae-mediated mechanism in different cell lines (Carlsson et al., 2007). In agreement, we observed that
soluble Gal-8 is early internalized by BMDCs on a lectin-glycan-dependent manner since lactose treatment
diminishes both Gal binding and endocytosis. Given its particular ‘‘heterodimeric’’ structure with two
distinct CRDs organized in tandem, Gal-8 can recognize ligands within a wide affinity range (Stowell
et al., 2008). Our mutant version of Gal-8 (Gal-8 mut), which only recognizes high-affinity ligands such as
poly-N-lactosamines and blood group antigens (Schroeder et al., 2016), similarly bound and entered
BMDCs. Since lactose only displaces the intermediate- and low-affinity (second best) ligands, our results
suggest that Gal-8 first binds with broad specificity to N-linked glycans at the BMDC surface prior to its
internalization and traffic along the endocytic compartments.
Changes in cell surface glycosylation and Gal expression appears to tailor lattice formation, further modifying
membrane dynamics (Mathew and Donaldson, 2019). Gal-built lattices were shown to modulate clathrin-inde-
pendent endocytosis of different glycosylated cargo proteins. Lakshminarayan et al. (2014) demonstrated that
Gal-3 binding toCD44 and a5b1 integrin triggers Gal oligomerization and its interactionwith glycosphingolipids
togeneratemembranecurvature, finally leading to the formation of endocytic ‘‘pits.’’On theother hand,Mathew
andDonaldson (2018) reported thatGal-3 canstimulateorcounteract the internalizationofCD59andMHC-Imol-
eculesdependingon the strengthofglycan interaction, latticeextension, andcell type. In this context, it is reason-
able to pose that Gal-8 with two active CRDs with different glycan specificity could alter membrane fluidity by
building a particular arrangement with glycoconjugates when exogenously added. In fact, it has been reported
very recently that extracellular Gal-8 drives endophilin-A3-dependent endocytosis of CD166, through its interac-
tionwithglycolipids locatedat the cellmembrane (Renardet al., 2020). In thiswork,weprovideevidence thatGal-
8-built lattice can induce soluble antigen internalization by APCs. Interestingly, soluble antigens seem to be re-
tainedor trappedon the outermembraneuponGal-8-glycan interaction before their uptake byAPCs. This initial
effect may constitute the first step for the enhanced antigen internalization. DCs can internalize OVA antigen by
mannose receptor aswell asmacropinocytosis (Burgdorfetal., 2007). It ispossible that,upon lattice formation, theiScience 23, 101278, July 24, 2020 9
Figure 5. BMDCs Pulsed with OVA and Gal-8 Present Antigen More Efficiently
(A) BMDCs were pulsed with 0.1 mg/mL OVA peptide (OVA323-339) or 500 mg/mL OVA protein (OVA) in the presence of
2 mM Gal-8 for 45 min at 37C, and then, cells were washed and co-cultured with CD4+ T cells purified from OT-II mice
splenocytes. Cell proliferation was determined after 72 h by [3H]-methylthymidine incorporation (right) or after 6 days by
CFSE dilution and flow cytometry analysis (left). IFN-g secretion was analyzed in supernatants from 6 days BMDC:CD4+
T cell co-cultures by ELISA.
(B) BMDCs were pulsed with 0.1 mg/mL OVA peptide (OVA323-339) or 1 mg/mL OVA protein (OVA) in the presence of 2 mM
Gal-8 ON at 37C. Then, cells were washed, fixed, and co-incubated with CD4+ T cells purified from OT-II mice
splenocytes. After 72 h of culture, cell proliferation was determined by [3H]-methylthymidine incorporation.
*p < 0.05, **p < 0.01, ****p < 0,0001, (t test). cpm: counts per minute. Bars represent the meanG SD. Depicted assays are




Articlescavengers and lectin-like receptors present in DC surface may display an increased avidity for their antigens.
Macropinocytosis, a typeof clathrin-independentendocytosis,wasalso showntobeaffectedbychanges inmem-
brane dynamics induced by Gal-lattices (Mathew and Donaldson, 2018). On the other hand, it was previously
shown that soluble Gal-8 or Gal-8 as a matrix component binds to cell surface integrins to induce PI3K-, Rac-1-
, and ERK-dependent actin cytoskeletal rearrangements leading to cell spreading and lamellipodial extensions
in several cell types (Cárcamo et al., 2006; Levy et al., 2001). In line with this, we observed that BMDCs cultured in
the presence of Gal-8 display a mature phenotype characterized by cell spreading and dendrites prolongation
(Carabelli et al., 2017). Since actin remodelingwas shown tobe involved in antigen pinocytosis of newly activated
DCs (Westetal., 2004), it is conceivable topose thatGal-8-inducedcell spreadingcouldalsoparticipate inantigen
uptakeenhancement. In supportofour findings,Obinoet al. (2018) have reported that exposureof specificBcells
toparticulate-antigencoatedwithGal-8 increased their internalizationcapacity in vivo, reinforcinga role forextra-
cellular Gal-8 in favoring the phagocytosis process as well.
Since we observed that OVA entered the cells in the same compartments as Gal-8 when offered together
(Figure 3A), we speculated that Gal-8 could be interacting with OVA (most probably in a lectin-glycan
dependent manner), thus explaining the increased antigen binding and uptake. However, after many ef-
forts performing OVA-Gal-8 pull-down assays, we were unable to demonstrate that these two proteins
were actually interacting, either by lectin-glycan or protein-protein manner. This outcome was not entirely
unexpected since OVA is highly decorated with mannose, a sugar that is not recognized by Gal-8
(Schroeder et al., 2016). Moreover, the non-glycosylated b-casein binding and uptake in APCs were also
increased in the presence of Gal-8, thus widening the spectrum of antigen nature and internalization mech-
anism for this Gal-8 effect. Therefore, our findings strengthen the notion that antigen binding and endo-
cytosis induction result frommembranemodifications induced by Gal-8-lattice formed with cellular surface
glycans, rather than a direct interaction between antigen and Gal-8.
In this work, we found that both Gal-8 and OVA were mainly localized in early endosomes soon after their inter-
nalization and practically excluded from the lysosomal compartments (Figure 3). The efficient proteolytic activity
for the delivered antigens in BMDCs could account for the apparent absence of these proteins in the degrada-
tive compartments. In agreement, other authors failed to detect OVA inside Rab-7+ or Lamp1+ vesicles in
BMDCs (Burgdorf et al., 2007; Franken et al., 2013). Moreover, Coria et al. (2016) were only able to trace OVA
antigen inside the Lamp2+ lysosomal compartment when BMDCs were co-delivered with a protease inhibitor.
Nevertheless, the joint internalization of Gal-8 and antigen did not affect the subsequent processing, as the
DQ-OVA substratewas degraded (Figure 4) and antigen-drivenCD4 T+ cell activationwas readily observed (Fig-
ure 5). On the other hand, it is already known that, according to the uptake mechanism, the antigen can follow




Article(Burgdorf et al., 2007). Soluble antigens intended for classical exogenous MHC-II-restricted presentation are
routed into lysosomes, whereas those destined for cross-presentation aremaintained in stable early endosomes
(Burgdorf and Kurts, 2008; Lutz et al., 1997). Although the present work is focused onGal-8-induced CD4+ T cell
response, we cannot discard that the antigen could be also following a cross-presentation route since soluble
OVA can be presented to both CD4+ and CD8+ T cells.
Both fluid-phase and receptor-mediated endocytic pathways rely on intracellular processing followed by
loading onto MHC-II molecules. Here, we observed that Gal-8-stimulated BMDCs and J774 macrophage
cell line display a major antigen processing ability not only as a consequence of an augmented internali-
zation but also due to an increased proteolysis rate. IL-6 signaling, which is involved in the Gal-8-induced
elicitation of CD4+ T cell antigenic response (Carabelli et al., 2018), was also shown to positively regulate
cathepsin S expression in DCs (Kim et al., 2017). However, Il6/ and WT BMDCs showed similar antigen
proteolysis in the presence of Gal-8, thus disregarding IL-6 signaling participation in Gal-8-induced antigen
processing. Considering that an increased fluorescent signal from degraded DQ-OVA implies more mol-
ecules being processed, Gal-8 could be promoting antigen degradation by modifying the traffic rate in
BMDC leading to an increased amount of antigen presented on the MHC-II context. Nevertheless, the
exact mechanism by which Gal-8 induces antigen degradation remains to be addressed.
In thepresentwork,wedemonstrated thatGal-8-inducedantigen internalizationandprocessing is traduced inan
incrementedpeptide-MHC-II complexespresentation to theCD4+T cells. Remarkably, CD4+Tcell responsewas
not recapitulatedusingOVA323-339 cognatepeptideas theantigensource, since itdoesnot require internalization
or further degradation, being able to directly accommodate ontoMHC-IImolecules at the APC surface (Santam-
brogioetal., 1999).Moreover, an increasedantigenpresentationwas still evidentwhenBMDCspreviouslypulsed
with antigen in the presence of Gal-8 were fixed before the co-culture with CD4+ T cells. Taken together, these
results reveal an intrinsic role of Gal-8 in antigen internalization, processing, and presentation that does not
depend on its previously reported costimulatory activity of CD4+ T cell response.
Activation of naive T helper (Th) cells requires three distinct signals delivered by DC, that integrated, delin-
eate the T cell differentiation process: inflammatory versus tolerogenic (Corthay, 2006). Signal I is delivered
by MHC-II in complex with a peptide processed from captured antigens and is received by a specific T cell
receptor. Signal II or costimulatory signal is mainly provided by the engagement of CD28 from the TCR
complex by CD80 and CD86 molecules on the DCs. This signal is mandatory since TCR signaling in the
absence of costimulation renders T cells anergic. Finally, signal III corresponds to soluble factors such as
IL-12, IL-15, IL-6, or TNF-a and is also important for functional activation of effector T cells. Notably, Gal-
8 reinforces each of the three signals required for the efficient elicitation of primary T cell responses.
Regarding the second signal, we have previously reported that this lectin can induce full maturation of
both BMDCs as well as splenic DCs, characterized by the upregulation of MHC-II, CD80, and CD86 surface
expression (Carabelli et al., 2017). More recently, we demonstrated that endogenous APCs secrete IL-6 in
response to Gal-8 stimulation and that cytokine signaling costimulates antigen recognition by cognate
CD4+ T cells, thus strengthening the third signal (Carabelli et al., 2018). Here, we demonstrate that Gal-
8 is also capable of reinforcing signal I, by enhancing antigen capture, processing, and presentation.
Notwithstanding the general assumption that, when DCs become activated, antigen uptake is negatively
regulated, whereas migration and antigen presentation ability are upregulated (Trombetta and Mellman,
2005), there is a time window soon after activation and before migration from tissues to lymphoid organs, in
which mature APCs display transient increased antigen internalization (Platt et al., 2010; West et al., 2004).
This implies that, at the very beginning of the adaptive immune response, Gal-8 can promote APCs matu-
ration as well as antigen uptake. It has been previously shown that Gal-8 expression is incremented in in-
flammatory conditions in several tissues and cells (reviewed in Tribulatti et al., 2020), suggesting a role for
the endogenous Gal in immune response and inflammation. Endothelial cells from both lymphatic and
vascular vessels may constitute an important in vivo source for secretedGal-8 in different peripheral tissues,
with the potential to deliver lectin activity to immature APCs (Cattaneo et al., 2014; Cueni and Detmar,
2009; Obino et al., 2018; Stancic et al., 2011; Thijssen et al., 2008). Gal-8 is also found in primary and sec-
ondary lymphoid organs, and Gal-8 mRNA was observed specifically in the paracortical T zone area of
lymph nodes (Obino et al., 2018; Tribulatti et al., 2007, 2009). It is therefore feasible that endogenous




ArticleWe have previously demonstrated that Gal-8 is expressed by BMDCs at the protein level and that its
expression is up-regulated during cell activation (Carabelli et al., 2017). These findings support the
notion that endogenous Gal-8 may bind to surface glycans after being secreted by BMDCs, thus acting
in an autocrine fashion. In line with this, BMDCs differentiated from Lgals8/ mice displayed impaired
capacity to promote antigen-specific CD4+ T cell activation (Carabelli et al., 2017). However, in the pre-
sent work, no differences in antigen internalization or degradation between immature Lgals8/ and WT
BMDCs were recorded. It is possible that, to form a lattice structure at the cell surface higher Gal-8
amounts are needed, as those reached with the exogenously added recombinant protein. In this regard,
it should be noted that recombinant protein concentration used throughout this work might resemble
the endogenous levels reached upon secretion, and remaining attached to the glycoconjugates at the
cell surface or the extracellular matrix, in a highly localized manner. BMDCs themselves express
increased levels of Gal-8 during activation, further suggesting that high amounts of Gal-8 can be avail-
able at the cell membrane particularly during a pro-inflammatory response. Alternatively, the apparent
lack of endogenous Gal-8 activity can be explained by the presence of lattices formed by other endog-
enous Gals members at the APC surface that may cooperate with Gal-8-induced antigen internalization
and processing. It has been reported that Gal-1 and Gal-3 are also synthesized by BMDCs at the protein
level (Hsu et al., 2009; Ilarregui et al., 2009). Interestingly, Gal-1 is secreted in large amounts by immature
BMDCs but, unlike Gal-8, its expression decreased substantially after maturation (Ilarregui et al., 2009).
Similar to Gal-8, intracellular Gal-3 expression was found incremented after BMDCs maturation; however,
its exposure at the outer membrane was almost marginal despite cellular activation status (Hsu et al.,
2009). These observations suggest Gal expression profile in BMDCs is likely to differ upon cell matura-
tion. Since redundant and antagonistic effects among Gal-1, Gal-3, and Gal-8 were observed in other
cellular responses when they were simultaneously present (Tribulatti et al., 2012; Weinmann et al.,
2018), it would be very interesting to establish in a near future which kind of interactions are taking place
among these Gals during antigen uptake and processing on APCs. In any case, the addition of exoge-
nous Gal-8 (even in the absence of the endogenous lectin) was sufficient to induce antigen internalization
and processing, as demonstrated in the present work.
Antigen uptake induction constitutes a desirable immunostimulatory property (Reed et al., 2013), actually
found among the mechanisms of action of safe and effective approved adjuvants like alum and MF59 (Ghi-
mire et al., 2012; O’Hagan et al., 2012). In the present study, we demonstrated that Gal-8-glycan interaction
at the cell surface can stimulate soluble antigen internalization by APCs, leading to a sustained antigen pre-
sentation. The adjuvant effect of exogenous Gal-8 has been previously explored by our group using an
experimental vaccine model. Co-administration of recombinant Gal-8 and inactivated foot-and-mouth dis-
ease virus (FMDV) elicited a major protective antibody-mediated response in BALB/cJ mice, compared
with the immunization with only viral antigen (Carabelli et al., 2017). In agreement with our findings, Obino
et al. (2018) showed that exogenously added Gal-8 is able to increase the number of antigen-specific
germinal center B cells and T follicular helper cells. As a mechanism of action, these authors demonstrated
that Gal-8 enhances particulate-antigen acquisition by B cells in vivo, promoting its presentation by stabi-
lizing the B-immune synapse and enhancing B cell responses.
In summary, the results presented in this work add to themechanisms of action of Gal-8 immunostimulatory
activity, and at the same time, position this lectin as an integral enhancer of the three required signals for an
effective antigen presentation.Limitations of the Study
This work was conducted using APCs differentiated in vitro from GM-CSF conditioned bone marrow cul-
tures (BMDCs), which comprise a heterogeneous population of DCs (GM-DC) and macrophages (GM-
M), as previously demonstrated (Carabelli et al., 2017; Helft et al., 2015). Although BMDCs constitute a
well-established model that has been largely used to study many aspects of APCs physiology, they might
not fully represent the endogenous DCs from an in vivo system.Resource Availability
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(2006). Galectin-8 binds specific b1 integrins and
induces polarized spreading highlighted by
asymmetric lamellipodia in Jurkat T cells. Exp.
Cell Res. 312, 374–386.
Carlsson, S., Oberg, C.T., Carlsson, M.C., Sundin,
A., Nilsson, U.J., Smith, D., Cummings, R.D.,
Almkvist, J., Karlsson, A., and Leffler, H. (2007).
Affinity of galectin-8 and its carbohydrate
recognition domains for ligands in solution and at
the cell surface. Glycobiology 17, 663–676.
Cattaneo, V., Tribulatti, M.V., and Campetella, O.
(2011). Galectin-8 tandem-repeat structure is
essential for T-cell proliferation but not for co-
stimulation. Biochem. J. 434, 153–160.
Cattaneo, V., Tribulatti, M.V., Carabelli, J.,
Carestia, A., Schattner, M., and Campetella, O.
(2014). Galectin-8 elicits pro-inflammatory
activities in the endothelium. Glycobiology 24,
966–973.Coria, L.M., Ibanez, A.E., Tkach, M., Sabbione, F.,
Bruno, L., Carabajal, M.V., Berguer, P.M.,
Barrionuevo, P., Schillaci, R., Trevani, A.S., et al.
(2016). A Brucella spp. protease inhibitor limits
antigen lysosomal proteolysis, increases cross-
presentation, and enhances CD8+ T cell
responses. J. Immunol. 196, 4014–4029.
Corthay, A. (2006). A three-cell model for
activation of naive T helper cells. Scand. J.
Immunol. 64, 93–96.
Cueni, L.N., and Detmar, M. (2009). Galectin-8
interacts with podoplanin and modulates
lymphatic endothelial cell functions. Exp. Cell
Res. 315, 1715–1723.
Elola, M.T., Wolfenstein-Todel, C., Troncoso,
M.F., Vasta, G.R., and Rabinovich, G.A. (2007).
Galectins: matricellular glycan-binding proteins
linking cell adhesion, migration, and survival. Cell
Mol. Life Sci. 64, 1679–1700.
Eshkar Sebban, L., Ronen, D., Levartovsky, D.,
Elkayam, O., Caspi, D., Aamar, S., Amital, H.,
Rubinow, A., Golan, I., Naor, D., et al. (2007). The
involvement of CD44 and its novel ligand
galectin-8 in apoptotic regulation of autoimmune




ArticleFranken, L., Kurts, C., and Burgdorf, S. (2013).
Monitoring the intracellular routing of
internalized antigens by immunofluorescence
microscopy. In Antigen Processing: Methods and
Protocols, P. van Endert, ed. (Humana Press),
pp. 371–377.
Furtak, V., Hatcher, F., and Ochieng, J. (2001).
Galectin-3 mediates the endocytosis of beta-1
integrins by breast carcinoma cells. Biochem.
Biophys. Res. Commun. 289, 845–850.
Ghimire, T.R., Benson, R.A., Garside, P., and
Brewer, J.M. (2012). Alum increases antigen
uptake, reduces antigen degradation and
sustains antigen presentation by DCs in vitro.
Immunol. Lett. 147, 55–62.
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µg/ml	 biotin-β-casein	 with	 the	 simultaneous	 addition	 of	 2	 µM	 Gal-8.	 Then,	 the	 internalization	
index	was	 calculated	as	 the	 ratio	between	 the	mean	of	 fluorescence	of	 treated	and	control	 cells.	









EEA1,	 -Rab5,	 -Lamp1	 and	 -Rab7.	 Quantification	 of	 colocalization	 of	 Gal-8	 signal	 in	Marker	 signal	
and	OVA	 signal	 in	Marker	 signal	was	 analyzed	with	Manders’	 overlap	 coefficient.	 Representative	
images	from	confocal	microscopy	are	shown.	Manders’	coefficients	were	calculated	using	the	JACOP	







Figure	 S3.	 Gal-8-induced	 antigen	 processing	 and	 presentation	 are	 not	 affected	 in	 IL-6-
deficient	 BMDCs,	 Related	 to	 Figure	 5.	 (A)	 BMDCs	 differentiated	 from	 Il6-/-	 or	 C57BL/6J	 (WT)	
mice	were	pulsed	with	50	µg/ml	DQ-OVA	and	2	µM	Gal-8	for	15	min	at	37°C,	washed	and	chased	
for	 45	 min.	 Fluorescence	 emitted	 by	 DQ-OVA	 was	 analyzed	 by	 flow	 cytometry.	 (B)	 BMDCs	
differentiated	from	Il6-/-	or	C57BL/6J	(WT)	mice	were	pulsed	with	0.1	µg/ml	OVA	peptide	(OVA323-
339)	 or	 1	 mg/ml	 OVA	 protein	 (OVA)	 in	 the	 presence	 of	 Gal-8	 for	 18h	 at	 37°C.	 Then,	 cells	 were	











from	Mutant	 Mouse	 Resource	 &	 Research	 Centers	 (MMRRC;	 University	 of	 California,	 Davis,	 CA,	
USA)	as	heterozygous.	After	in-house	12	backcrosses	to	C57BL/6J,	a	homozygous	knockout	colony	
with	 95%	 of	 the	 C57BL/6J	 genetic	 background	 was	 established,	 as	 assessed	 at	 The	 Jackson	
Laboratory	 Genotyping	 Resources.	 The	 Ethics	 Committee	 Board	 of	 the	 Universidad	 Nacional	 de	
San	 Martín	 approved	 all	 procedures	 involving	 animals.	 Immortalized	 murine	 macrophage-like	
J774	 A.1	 cell	 line	 (ATCC®	 TIB-67™)	was	maintained	 by	weekly	 passages	 in	 RPMI	 1640	 (Gibco,	






For	 DC	 phenotyping,	 fluorochrome-conjugated	 anti-CD11c	 (clone:	 M1/70),	 anti-MHC-II	 (clone:	
M5/114.15.2),	 anti-CD80	 (clone:	 PO3)	 and	 anti-CD86	 (clone:	 1610A1)	 mAbs	 were	 used	
(BioLegend).	Anti-EEA1	(clone:	C45B10)	and	anti-Rab5	(clone:	C8B1)	mAbs	were	obtained	 from	
Cell	Signaling	Technology.	Anti-Rab7	(clone:	W16034A)	and	Alexa	647	anti-Lamp1	(clone:	1D4B)	
mAbs,	 Alexa	 647anti-rabbit	 (Poly4064)	 and	 anti-rat	 (Poly4054)	 immunoglobulins	 secondary	
polyclonal	antibodies,	and	PE/Cy5-conjugated	streptavidin	were	all	obtained	from	Biolegend.	For	
ELISA,	biotin	anti-mouse	IFN-γ	(clone:	XMG1.2),	purified	anti-mouse	IFN-γ	(clone:	R4-6A2),	biotin	






To	 obtain	 recombinant	 Gal-8,	 mouse	 Gal-8L	 isoform	 (GenBank:	 EF524570)	 was	 cloned	 by	 PCR	
using	cDNA	as	a	template,	obtained	from	thymocytes	mRNA	by	retrotranscription	(Tribulatti	et	al.,	
2007).	 The	 amplified	 open	 reading	 frame	 was	 cloned	 into	 pTrcHis	 B	 (Invitrogen)	 expression	
plasmid	 and	 transformed	 into	Escherichia	 coli	BL-21.	 Overnight	 cultures	were	 diluted	 1/100	 in	
500	 mL	 of	 Terrific	 Broth	 (USB	 Bio)	 plus	 ampicillin,	 and	 incubated	 with	 agitation	 at	 37°C.	 At	
OD600nm=1,	 0.5mM	 isopropyl-ß-D-thio	 galactopyranoside	 (Sigma-Aldrich,	 St	 Louis,	 MO)	 was	
added	and	the	culture	was	incubated	for	18	h	at	18°C	with	agitation.	The	pellet	was	resuspended	
in	 30	 mL	 of	 buffer	 1X	 PBS	 containing	 0.5%	 Triton	 X-100,	 2	 mM	 EDTA	 and	 1	 mM	
phenylmethylsulfonyl	fluoride	(PMSF),	pH	7.4,	and	lysed	by	sonication.	Cell	debris	was	removed	by	
centrifugation	 at	 4°C.	 The	 soluble	 extract	were	 filtered	 through	 a	 0.45	 μm	 pore	membrane	 and	
seeded	 into	 a	 1mL	 Lactosyl-Sepharose	 column	 (Sigma-Aldrich).	 After	 washing	 with	 twenty	
volumes	 of	 1X	 PBS,	 the	 lectin	 was	 eluted	 with	 10	 mL	 of	 1X	 PBS	 plus	 100	 mM	 lactose	 (Sigma-
Aldrich)	and	1mM	PMSF.	Then,	protein	eluate	was	diluted	in	equilibration	buffer	(20	mM	Tris–HCl	
pH	8.8,	500	mM	NaCl,	30	mM	imidazole),	and	seeded	into	a	previously	equilibrated	1	mL	His-Trap	
Column,	 (GE-Healthcare,	 Uppsala,	 Sweden).	 After	 washing	 the	 column	 with	 ten	 volumes	 of	




described	 previously	 for	 Gal-8	 were	 followed,	 except	 for	 purification,	 where	 two	 consecutive	
rounds	 of	 immobilized	 metal-affinity	 chromatography	 were	 performed,	 owing	 to	 the	 lack	 of	




were	 eliminated	 using	 Pierce	 High-Capacity	 Endotoxin	 removal	 resin	 (ThermoFisher	 Scientific)	
following	manufacturer’s	 instructions,	resulting	 in	 less	 than	0.1	endotoxin	units	per	milligram	of	








Alexa-labeled	 proteins	 were	 prepared	 according	 to	 the	 manufacturer’s	 instructions	 (Protein	
labeling	 Kit,	 Molecular	 Probes,	 ThermoFisher	 Scientific).	 Briefly,	 1	 mg	 of	 Gal-8	 or	 chicken	 egg	
ovalbumin	 (OVA,	 Grade	 V,	 Sigma-Aldrich)	 was	 incubated	 with	 the	 corresponding	 dye	 and	 then	
labeled	protein	was	purified	 on	 a	molecular	 exclusion	 column.	Recovered	protein	 concentration	









Bone	 marrow	 (BM)	 was	 obtained	 from	 femurs	 and	 tibias	 from	 6-	 to	 10-wk-old	 male	 mice	 by	
flushing	RPMI	1640	medium	through	the	bone	interior.	The	cell	suspension	was	washed	and	RBC	
were	lysed	with	RBC	lysis	buffer	(Sigma-Aldrich).	Then,	cells	were	cultured	at	37°C	and	5%	CO2	in	
six-well	 plates	 (1.5	 x	 106	 cells	 per	 well)	 in	 2	 ml	 RPMI	 1640	 containing	 10%	 FBS,	 50	 μg/ml	







BMDCs	(2x105)	differentiated	 from	BALB/cJ	males	were	 incubated	 for	different	periods	with	0.2	
µM	Alexa	568-Gal-8	plus	1.8	µM	of	unlabeled	Gal-8	alone,	or	in	combination	with	Alexa	488-OVA	




one	 of	 the	 following	 primary	 antibodies	 in	 0.1%	 saponin,	 1%	 BSA,	 1X	 PBS	 solution:	 anti-EEA1	
(1:500),	anti-Rab5	(1:200),	anti-Rab7	(1:200)	and	anti-Lamp1	(1:600),	followed	by	1	h	incubation	
at	 room	 temperature	 with	 secondary	 antibodies.	 Cells	 were	 mounted	 in	 fluorescent	 mounting	













BMDCs	 (2x105)	 differentiated	 from	 BALB/cJ	males	were	 resuspended	 in	 100	 μl	 of	 ice-cold	 PBS	
containing	 sodium	azide	and	 treated	with	0.1	μM	Alexa	488-Gal-8	on	 ice	 for	20	min.	Then,	 cells	








presence	 of	 antigen	 (50	 µg/ml	 Alexa	 488-OVA	 or	 biotin-β-casein),	 at	 37°C	 and	 5%	 CO2	 for	
internalization,	or	on	ice	for	surface	binding,	with	or	without	2	µM	Gal-8.	For	intracellular	biotin-β-
casein	 visualization,	 cells	 were	 washed	 with	 ice-cold	 PBS	 and	 fixed	 and	 permeabilized	 with	
Cytofix/Cytoperm	Fixation/Permeabilization	Solution	(BD,	Franklin	Lakes,	NJ)	 for	20	min	at	4°C.	
Then	 cells	 were	 stained	 with	 1:1000	 PE-Cy5-streptavidin.	 For	 surface-bound	 biotin-β-casein	
visualization,	cells	were	stained	as	before,	but	without	permeabilization.	Then,	cells	were	washed	
with	ice-cold	PBS	containing	sodium	azide	and	analyzed	by	flow	cytometry.	When	indicated,	PBS	
plus	 100	 mM	 lactose	 was	 added.	 Cell	 samples	 processed	 without	 antigen	 were	 included	 as	 a	
negative	 control.	 For	 antigen	 binding	 analysis	 by	 confocal	 microscopy,	 2x105	 BMDCs	 were	
incubated	with	Alexa	488-OVA	in	the	presence	of	2	µM	of	unlabeled	Gal-8	for	15	min	on	ice.	When	
indicated,	 PBS	 plus	 100	mM	 lactose	was	 added.	 Then,	 cells	were	washed	with	 ice-cold	 PBS	 and	










samples	 were	 washed	 and	 eluted	 with	 PBS	 plus	 200	 mM	 lactose.	 Eluates	 (for	 lectin-glycan	
interaction)	and	resins	 (for	protein-protein	 interaction)	were	cracked	and	solved	 in	a	10%	SDS-	
PAGE	 before	 transferred	 to	 nitrocellulose	 membranes.	 Blots	 were	 probed	 with	 anti-Gal-8	
polyclonal	 antibody	 1/200,	 and	 mouse	 monoclonal	 anti-OVA	 antibody	 1/2000	 (MAbia	 labs,	
Buenos	Aires,	Argentina),	followed	by	goat	anti-rabbit	IgG	IRDye	680LT	and	goat	anti-mouse	IgG	






BMDCs	 (5x105)	 differentiated	 from	 BALB/cJ	 males	 were	 incubated	 with	 50	 µg/ml	 DQ-OVA	
(ThermoFisher	 Scientific)	 for	 the	 indicated	 periods	 at	 37°C	 and	 5%	 CO2.	 After	 Gal-8-treatment,	
cells	were	washed	and	analyzed	by	flow	cytometry.	For	simultaneous	antigen	internalization	and	
processing	assay,	cells	were	incubated	with	50	µg/ml	DQ-OVA	together	with	50	µg/ml	biotin-OVA.	
After	 incubation,	 cells	 were	 washed	 with	 ice-cold	 PBS	 and	 fixed	 and	 permeabilized	 with	







For	 mouse	 splenocyte	 purification,	 spleens	 from	 6–	 to	 8-wk-old	 male	 mice	 were	 removed	 and	
disrupted	against	a	stainless	steel	mesh	in	RPMI	1640	medium.	Cell	suspension	was	washed,	then	
RBC	were	lysed	with	RBC	lysis	buffer	and	cells	were	washed	again	with	medium.	For	CD4+	T	cell	
purification,	 a	 MojoSort	 Mouse	 CD4	 Naive	 Cell	 Untouched	 Isolation	 Kit	 (BioLegend)	 was	 used,	
following	 the	 manufacturer’s	 instructions.	 Cell	 purity	 (>90%)	 was	 checked	 by	 flow	 cytometry,	
after	 cell	 staining	 with	 anti-CD4	 mAb	 (clone:	 GK1.5,	 BioLegend).	 BMDCs	 (104)	 from	 C57BL/6J	
males	were	cultured	in	a	96-round	bottom	well	plate	with	100	μl	RPMI	1640	containing	10%	FBS,	
50	 μg/ml	 Gentamycin	 in	 the	 presence	 of	 the	 cognate	 ovalbumin	 323-339	 (OVA323–339)	 peptide	
(Genscript,	 Piscataway,	 NJ)	 or	 EndoGrade®	 Endotoxin-free	 Ovalbumin	 (Hygloss,	 Bernried	 am	
Starnberger	See,	Germany)	at	the	indicated	concentrations,	plus	2	μM	Gal-8	during	45	min	at	37°C	
and	5%	CO2.	For	fixed	BMDCs	assays,	cells	were	washed	afther	the	pulse	with	ice-cold	PBS,	fixed	
for	1	min	on	 ice-cold	glutaraldehyde	 (0.03%	 in	PBS:RPMI	1:1),	 and	quenched	with	glycine	 (100	
mM	 in	PBS:RPMI	1:1).	Then,	 cells	were	washed	 several	 times	with	 ice-cold	PBS	and	 co-cultured	





same	volume	of	5	μM	CFSE	 in	PBS	and	 incubated	 for	15	min	at	37°C.	Subsequently,	 the	reaction	







IFN-γ	 levels	were	quantified	by	 commercial	 ELISA	 antibodies	 (BioLegend)	 in	 supernatants	 from	












Statistical	 analyses	 and	 graphs	 were	 performed	 with	 GraphPad	 Prism	 6.0.	 Student’s	 t	 test	 was	
used,	except	for	the	analysis	shown	in	Fig	4D,	where	ordinary	one-way	ANOVA	was	performed.	In	
all	cases,	P	values	<	0.05	were	considered	significant.		
